42706 Federal Register / Vol. 82, No. 174 / Monday, September 11, 2017 / Notices 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection 

(check justification or form 83): 

Revision of a currently approved 

collection. 

2. The Title of the Form/Collection: 

Application and Permit for Temporary 

Importation of Firearms and 

Ammunition By Nonimmigrant Aliens. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form number (if applicable): ATF F 

6NIA (5330.3D). 

Component: Bureau of Alcohol, 

Tobacco, Firearms and Explosives, U.S. 

Department of Justice. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Primary: Individuals or households. 

Other (if applicable): None. 

Abstract: The form allows 

nonimmigrant aliens to temporarily 

import firearms and ammunition into 

the United States for hunting or other 

sporting purposes. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: An estimated 15,000 

respondents will utilize the form, and it 

will take each respondent 

approximately 30 minutes to complete 

the form. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated annual public 

burden associated with this collection is 

7,500 hours which is equal to 15,000 

(the total # of respondents) * .5 (30 

minutes). 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE., 3E.405A, 

Washington, DC 20530. 

Dated: September 6, 2017. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2017–19132 Filed 9–8–17; 8:45 am] 

BILLING CODE 4410–FY–P 

EXECUTIVE OFFICE OF THE 

PRESIDENT 

Office of National Drug Control Policy 

Notification of a Public Meeting of the 

President’s Commission on Combating 

Drug Addiction and the Opioid Crisis 

(Commission) 

AGENCY: Office of National Drug Control 

Policy (ONDCP), Executive Office of the 

President. 

ACTION: Notice of meeting. 

SUMMARY: ONDCP announces the third 

meeting of the President’s Commission 

on Combating Drug Addiction and the 

Opioid Crisis to advance the 

Commission’s work on drug issues and 

the opioid crisis per Executive Order 

13784. The meeting will consist of 

statements to the Commission from 

invited government, nonprofit, and 

business organizations regarding 

Innovative Pain Management and 

Prevention Measures for Diversion 

followed by discussion of the issues 

raised. 

DATES: The Commission meeting will be 

held on Wednesday September 27, 2017 

from 12:30 p.m. until approximately 

2:30 p.m. (Eastern Time). 

ADDRESSES: The meeting will be held at 

the Eisenhower Executive Office 

Building, Room 350, in the Executive 

Office of the President in Washington, 

DC. It will be open to the public through 

livestreaming on https://

www.whitehouse.gov/live. 

FOR FURTHER INFORMATION CONTACT: 

General information concerning the 

Commission and its meetings can be 

found on ONDCP’s Web site at https:// 

www.whitehouse.gov/ondcp/presidentscommission. Any member of the public 

who wishes to obtain information about 

the Commission or its meetings that is 

not already on ONDCP’s Web site or 

who wishes to submit written comments 

for the Commission’s consideration may 

contact Michael Passante, Designated 

Federal Officer (DFO) via email at 

commission@ondcp.eop.gov or 

telephone at (202) 395–6709. Please 

note that ONDCP may post such written 

comments publicly on our Web site, 

including names and contact 

information that are submitted. There 

will not be oral comments from the 

public at the meeting. Requests to 

accommodate disabilities with respect 

to livestreaming or otherwise should 

also be sent to that email address, 

preferably at least 10 days prior to the 

meeting to allow time for processing. 

SUPPLEMENTARY INFORMATION: The 

Commission was established in 

accordance with E.O. 13784 of March 

29, 2017, the Commission’s charter, and 

the provisions of the Federal Advisory 

Committee Act (FACA), as amended, 5 

U.S.C. App. 2, to obtain advice and 

recommendations for the President 

regarding drug issues. The Executive 

Order, charter, and information on the 

Members of the Commission are 

available on ONDCP’s Web site. The 

Commission will function solely as an 

advisory body and will make 

recommendations regarding policies 

and practices for combating drug 

addiction with particular focus on the 

current opioid crisis in the United 

States. The Commission’s final report is 

due October 1, 2017 unless there is an 

extension. Per E.O. 13784, the 

Commission shall: 

a. Identify and describe the existing 

Federal funding used to combat drug 

addiction and the opioid crisis; 

b. assess the availability and 

accessibility of drug addiction treatment 

services and overdose reversal 

throughout the country and identify 

areas that are underserved; 

c. identify and report on best practices 

for addiction prevention, including 

healthcare provider education and 

evaluation of prescription practices, 

collaboration between State and Federal 

officials, and the use and effectiveness 

of State prescription drug monitoring 

programs; 

d. review the literature evaluating the 

effectiveness of educational messages 

for youth and adults with respect to 

prescription and illicit opioids; 

e. identify and evaluate existing 

Federal programs to prevent and treat 

drug addiction for their scope and 

effectiveness, and make 

recommendations for improving these 

programs; and 

f. make recommendations to the 

President for improving the Federal 

response to drug addiction and the 

opioid crisis. 

Dated: September 6, 2017. 

Michael Passante, 

Deputy General Counsel, Designated Federal 

Officer. 

[FR Doc. 2017–19186 Filed 9–8–17; 8:45 am] 

BILLING CODE 3280–F5–P 


asabaliauskas on DSKBBXCHB2PROD with NOTICES